Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blunt

Showing results (681-690 of 716) with videos related to

Pageof 72
Sort By:
Neuroimage|May 16, 2023
Comparisons of electrophysiological markers of impaired executive attention after traumatic brain injury and in healthy agingNayoung Kim, Keith Jamison, Abhishek Jaywant, et al.
Leukemia|October 22, 2015
The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1M Larrayoz, S J Blakemore, R C Dobson, et al.
Journal of the American Chemical Society|June 5, 2024
Environment-Driven Variability in Absolute Band Edge Positions and Work Functions of Reduced CeriaXingfan Zhang, Christopher Blackman, Robert G Palgrave, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2006
Identification of novel pyrazole acid antagonists for the EP1 receptorStephen C McKeown, Adrian Hall, Gerard M P Giblin, et al.
Frontiers in Oncology|September 17, 2024
KIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodiesLara V Graham, Jack G Fisher, Amber D P Doyle, et al.
Leukemia|August 1, 2023
XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expressionJack G Fisher, Amber D P Doyle, Lara V Graham, et al.
BMC Public Health|February 9, 2017
HealtheSteps™ Study Protocol: a pragmatic randomized controlled trial promoting active living and healthy lifestyles in at-risk Canadian adults delivered in primary care and community-based clinicsDawn P Gill, Wendy Blunt, Cassandra Bartol, et al.
Toxicology Research|April 1, 2025
Microsampling in toxicology studies - maximising the scientific, business and 3Rs advantagesHelen Prior, Adeyemi O Adedeji, Romalie Allen, et al.
Journal of the American Geriatrics Society|March 19, 2021
Community health worker interventions for older adults with complex health needs: A systematic reviewMeaghan A Kennedy, Kayla E Hatchell, Peter R DiMilia, et al.
British Journal of Cancer|October 16, 2018
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancerDavide Melisi, Rocio Garcia-Carbonero, Teresa Macarulla, et al.
Pageof 72

Showing results (681-690 of 716) with videos related to

Sort By:
Pageof 72
Neuroimage|May 16, 2023
Comparisons of electrophysiological markers of impaired executive attention after traumatic brain injury and in healthy agingNayoung Kim, Keith Jamison, Abhishek Jaywant, et al.
Leukemia|October 22, 2015
The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1M Larrayoz, S J Blakemore, R C Dobson, et al.
Journal of the American Chemical Society|June 5, 2024
Environment-Driven Variability in Absolute Band Edge Positions and Work Functions of Reduced CeriaXingfan Zhang, Christopher Blackman, Robert G Palgrave, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2006
Identification of novel pyrazole acid antagonists for the EP1 receptorStephen C McKeown, Adrian Hall, Gerard M P Giblin, et al.
Frontiers in Oncology|September 17, 2024
KIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodiesLara V Graham, Jack G Fisher, Amber D P Doyle, et al.
Leukemia|August 1, 2023
XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expressionJack G Fisher, Amber D P Doyle, Lara V Graham, et al.
BMC Public Health|February 9, 2017
HealtheSteps™ Study Protocol: a pragmatic randomized controlled trial promoting active living and healthy lifestyles in at-risk Canadian adults delivered in primary care and community-based clinicsDawn P Gill, Wendy Blunt, Cassandra Bartol, et al.
Toxicology Research|April 1, 2025
Microsampling in toxicology studies - maximising the scientific, business and 3Rs advantagesHelen Prior, Adeyemi O Adedeji, Romalie Allen, et al.
Journal of the American Geriatrics Society|March 19, 2021
Community health worker interventions for older adults with complex health needs: A systematic reviewMeaghan A Kennedy, Kayla E Hatchell, Peter R DiMilia, et al.
British Journal of Cancer|October 16, 2018
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancerDavide Melisi, Rocio Garcia-Carbonero, Teresa Macarulla, et al.
Pageof 72